ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

Abstract Background N6-methyladenosine (m6A) modification is an emerging layer of epigenetic regulation which is widely implicated in the tumorigenicity of hepatocellular carcinoma (HCC), offering a novel perspective for investigating molecular pathogenesis of this disease. The role of AlkB homolog...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yunhao Chen, Yanchun Zhao, Junru Chen, Chuanhui Peng, Yanpeng Zhang, Rongliang Tong, Qiyang Cheng, Beng Yang, Xiaode Feng, Yuejie Lu, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2020-08-01
Ráidu:	Molecular Cancer
Fáttát:	N6-methyladenosine (m6A) Hepatocellular carcinoma (HCC) ALKBH5 LYPD1
Liŋkkat:	http://link.springer.com/article/10.1186/s12943-020-01239-w
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!